Rejected CIRM Grant Applicant Seeks Reversal of Action
One of the rejected applicants for CIRM's $263 million in lab construction grants has asked the agency's directors to reverse the decision and fund an effort that has an "immediate and broad application" in the treatment of sickle cell anemia.
Bertram Lubin, president of the Children's Hospital Oakland Research Institute, wrote members of the CIRM Overs…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.